bonyf Advances to Phase 3 in the Development of Al
Post# of 107025

Clinical Study Confirms Exceptional Performance and High Tolerability
Knokke-Heist (Belgium), 8 April 2025, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), a leader in dental
consumer goods and professional dental consumables, announces that it has successfully
advanced to Phase 3 in the development of its innovative Alginate-Organic Olive-oil based
Denture Fixative Cream following a positive clinical-dermatological application study
conducted by Dermatest GmbH (Germany).
https://bonyf.com/wp-content/uploads/2025/04/...0Cream.pdf

